Literature DB >> 25805497

STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization.

Miroslava Didiasova1, Dariusz Zakrzewicz1, Viktor Magdolen2, Chandran Nagaraj3, Zoltán Bálint3, Manfred Rohde4, Klaus T Preissner1, Malgorzata Wygrecka5.   

Abstract

Tumor cells use broad spectrum proteolytic activity of plasmin to invade tissue and form metastatic foci. Cell surface-associated enolase-1 (ENO-1) enhances plasmin formation and thus participates in the regulation of pericellular proteolysis. Although increased levels of cell surface bound ENO-1 have been described in different types of cancer, the molecular mechanism responsible for ENO-1 exteriorization remains elusive. In the present study, increased ENO-1 protein levels were found in ductal breast carcinoma and on the cell surface of highly metastatic breast cancer cell line MDA-MB-231. Elevated cell surface-associated ENO-1 expression correlated with augmented MDA-MB-231 cell migratory and invasive properties. Exposure of MDA-MB-231 cells to LPS potentiated translocation of ENO-1 to the cell surface and its release into the extracellular space in the form of exosomes. These effects were independent of de novo protein synthesis and did not require the classical endoplasmic reticulum/Golgi pathway. LPS-triggered ENO-1 exteriorization was suppressed by pretreatment of MDA-MB-231 cells with the Ca(2+) chelator BAPTA or an inhibitor of endoplasmic reticulum Ca(2+)-ATPase pump, cyclopiazonic acid. In line with these observations, the stromal interaction molecule (STIM) 1 and the calcium release-activated calcium modulator (ORAI) 1-mediated store-operated Ca(2+) entry were found to regulate LPS-induced ENO-1 exteriorization. Pharmacological blockage or knockdown of STIM1 or ORAI1 reduced ENO-1-dependent migration of MDA-MB-231 cells. Collectively, our results demonstrate the pivotal role of store-operated Ca(2+) channel-mediated Ca(2+) influx in the regulation of ENO-1 exteriorization and thus in the modulation of cancer cell migratory and invasive properties.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  calcium; cancer; enolase-1; inflammation; membrane trafficking; stromal interaction molecule 1 (STIM1)

Mesh:

Substances:

Year:  2015        PMID: 25805497      PMCID: PMC4424336          DOI: 10.1074/jbc.M114.598425

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2.

Authors:  Mallika Valapala; Jamboor K Vishwanatha
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

Review 2.  α-Enolase: a promising therapeutic and diagnostic tumor target.

Authors:  Michela Capello; Sammy Ferri-Borgogno; Paola Cappello; Francesco Novelli
Journal:  FEBS J       Date:  2011-02-24       Impact factor: 5.542

3.  Primers on molecular pathways: lipopolysaccharide signaling - potential role in pancreatitis and pancreatic cancer.

Authors:  Jose L Del Pozo
Journal:  Pancreatology       Date:  2010-05-12       Impact factor: 3.996

Review 4.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

Review 5.  Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage.

Authors:  Sergei I Grivennikov; Michael Karin
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

6.  Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation.

Authors:  Rajesh Kumar Gandhirajan; Shu Meng; Harish C Chandramoorthy; Karthik Mallilankaraman; Salvatore Mancarella; Hui Gao; Roshanak Razmpour; Xiao-Feng Yang; Steven R Houser; Ju Chen; Walter J Koch; Hong Wang; Jonathan Soboloff; Donald L Gill; Muniswamy Madesh
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

7.  TLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3 cells induced by lipopolysaccharide.

Authors:  Zengyang Pei; Degui Lin; Xiaoyu Song; Hui Li; Haifeng Yao
Journal:  Cell Immunol       Date:  2008-07-22       Impact factor: 4.868

8.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

9.  The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.

Authors:  E F Plow; D E Freaney; J Plescia; L A Miles
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

Review 10.  Remodeling of calcium signaling in tumor progression.

Authors:  Yih-Fung Chen; Ying-Ting Chen; Wen-Tai Chiu; Meng-Ru Shen
Journal:  J Biomed Sci       Date:  2013-04-17       Impact factor: 8.410

View more
  15 in total

Review 1.  Ca2+ Signalling and Hypoxia/Acidic Tumour Microenvironment Interplay in Tumour Progression.

Authors:  Madelaine Magalì Audero; Natalia Prevarskaya; Alessandra Fiorio Pla
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

2.  A new selective pharmacological enhancer of the Orai1 Ca2+ channel reveals roles for Orai1 in smooth and skeletal muscle functions.

Authors:  Iman Azimi; Ralph J Stevenson; Xuexin Zhang; Aldo Meizoso-Huesca; Ping Xin; Martin Johnson; Jack U Flanagan; Silke B Chalmers; Ryan E Yoast; Jeevak S Kapure; Benjamin P Ross; Irina Vetter; Mark R Ashton; Bradley S Launikonis; William A Denny; Mohamed Trebak; Gregory R Monteith
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-13

3.  Anti-proliferative Effects of Nucleotides on Gastric Cancer via a Novel P2Y6/SOCE/Ca2+/β-catenin Pathway.

Authors:  Hanxing Wan; Rui Xie; Jiangyu Xu; Jialin He; Bo Tang; Qingqing Liu; Sumin Wang; Yanjun Guo; Xin Yang; Tobias Xiao Dong; John M Carethers; Shiming Yang; Hui Dong
Journal:  Sci Rep       Date:  2017-05-26       Impact factor: 4.379

4.  Pro-invasive stimuli and the interacting protein Hsp70 favour the route of alpha-enolase to the cell surface.

Authors:  Giovanni Perconti; Cristina Maranto; Daniele P Romancino; Patrizia Rubino; Salvatore Feo; Antonella Bongiovanni; Agata Giallongo
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

5.  STIM1 overexpression in hypoxia microenvironment contributes to pancreatic carcinoma progression.

Authors:  Jian Wang; Junling Shen; Kaili Zhao; Jinmeng Hu; Jiuxing Dong; Jianwei Sun
Journal:  Cancer Biol Med       Date:  2019-02       Impact factor: 4.248

Review 6.  Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis.

Authors:  Yufang Tan; Xiao Luo; Wenchang Lv; Weijie Hu; Chongru Zhao; Mingchen Xiong; Yi Yi; Dawei Wang; Yichen Wang; Haiping Wang; Yiping Wu; Qi Zhang
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

7.  A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells.

Authors:  Shenq-Shyang Huang; Wen-Ying Liao; Chung-Chi Hsu; Tze-Sian Chan; Tai-Yan Liao; Pei-Ming Yang; Li-Tzong Chen; Shian-Ying Sung; Kelvin K Tsai
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

Review 8.  Ion Channels in Brain Metastasis.

Authors:  Lukas Klumpp; Efe C Sezgin; Franziska Eckert; Stephan M Huber
Journal:  Int J Mol Sci       Date:  2016-09-08       Impact factor: 5.923

9.  FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma.

Authors:  Lisha Qi; Wangzhao Song; Lingmei Li; Lu Cao; Yue Yu; Chunmin Song; Yalei Wang; Fei Zhang; Yang Li; Bin Zhang; Wenfeng Cao
Journal:  Oncotarget       Date:  2016-11-08

10.  A Ca2+-stimulated exosome release pathway in cancer cells is regulated by Munc13-4.

Authors:  Scott W Messenger; Sang Su Woo; Zhongze Sun; Thomas F J Martin
Journal:  J Cell Biol       Date:  2018-06-21       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.